REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

21/11/2018 10:00

RNS Number : 0705I
Morgan Stanley
21 November 2018
 


 
FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


20 NOVEMBER 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES - Shire plc



 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



 
Class of relevant security:


 
Ordinary




 
 


Interests


Short positions




Number


%


Number


%




(1) Relevant securities owned and/or controlled:


11,549,723


1.47


29,590,637


3.77




(2) Cash-settled derivatives:
 


29,049,709


3.70


10,705,471


1.37




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


315,000


0.04


315,000


0.04




 
     TOTAL:


40,914,432


5.21


40,611,108


5.18



 
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:


N/A




Details, including nature of the rights concerned and relevant percentages:


N/A



 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


 Purchases/sales


 Total   number of securities


 Highest price per unit paid/received


 Lowest price per unit paid/received




 Ordinary


 PURCHASES


 1,534,991


 4,476.0000 JPY


 4,295.1461 JPY




 Ordinary


 SALES


 1,104,191


 4,476.0000 JPY


 4,295.1461 JPY



 
 (b)       Cash-settled derivative transactions
 



Class of relevant security


 Product description
            e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per unit




Ordinary


CFD


SHORT


200


4370.0000 JPY




Ordinary


CFD


LONG


200


4414.5000 JPY




Ordinary


CFD


LONG


7100


4438.3380 JPY




Ordinary


CFD


SHORT


2100


4424.5200 JPY




Ordinary


CFD


SHORT


100


4426.0000 JPY




Ordinary


CFD


LONG


4900


4419.1065 JPY




Ordinary


CFD


SHORT


1200


4403.8291 JPY




Ordinary


CFD


SHORT


100


4422.0000 JPY




Ordinary


CFD


SHORT


700


4416.2857 JPY




Ordinary


CFD


LONG


26100


4425.5134 JPY




Ordinary


CFD


SHORT


3900


4476.0000 JPY




Ordinary


CFD


SHORT


100


4397.0000 JPY




Ordinary


CFD


SHORT


600


4431.5000 JPY




Ordinary


CFD


LONG


23500


4399.1638 JPY




Ordinary


CFD


LONG


6400


4373.2500 JPY




Ordinary


CFD


SHORT


8200


4417.6951 JPY




Ordinary


CFD


SHORT


6900


4476.0000 JPY




Ordinary


CFD


SHORT


300


4455.0000 JPY




Ordinary


CFD


LONG


20700


4436.3768 JPY




Ordinary


CFD


SHORT


6200


4426.6129 JPY




Ordinary


CFD


LONG


4800


4442.4791 JPY




Ordinary


CFD


SHORT


600


4409.0000 JPY




Ordinary


CFD


LONG


3800


4428.3157 JPY




Ordinary


CFD


SHORT


300


4436.0000 JPY




Ordinary


CFD


LONG


300


4370.0000 JPY




Ordinary


CFD


SHORT


8700


4413.5172 JPY




Ordinary


CFD


LONG


35000


4433.7957 JPY




Ordinary


CFD


LONG


500


4460.8000 JPY




Ordinary


CFD


LONG


600


4423.3333 JPY




Ordinary


CFD


LONG


9900


4423.7272 JPY




Ordinary


CFD


SHORT


100


4451.0000 JPY




Ordinary


CFD


LONG


15100


4443.7211 JPY




Ordinary


CFD


SHORT


620000


4432.1759 JPY




Ordinary


CFD


LONG


56200


4423.8700 JPY




Ordinary


CFD


SHORT


2100


4445.8095 JPY




Ordinary


CFD


LONG


1000


4459.0000 JPY




Ordinary


CFD


LONG


35100


4437.2891 JPY




Ordinary


CFD


SHORT


20200


4450.5345 JPY



 
 (c)       Stock-settled derivative transactions (including options)               
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


 Product description             e.g. call option


 Writing, purchasing, selling, varying etc.


 Number of securities to which option relates


 Exercise price per unit


 Type   e.g. American, European etc.


 Expiry date


 Option money paid/ received per unit




 Ordinary


 PUT


 PURCHASE


 65,000


 4,414.0000


 E


 14/06/2019


 346.4990 JPY




 Ordinary


 CALL


 PURCHASE


 65,000


 4,414.0000


 E


 14/06/2019


 346.4990 JPY




 Ordinary


 PUT


 PURCHASE


 65,000


 4,414.0000


 E


 13/12/2019


 413.5918 JPY




 Ordinary


 CALL


 PURCHASE


 65,000


 4,414.0000


 E


 13/12/2019


 414.0332 JPY



 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




N/A


N/A


N/A


N/A


N/A



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)




N/A


N/A


N/A


N/A



 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


YES



 
 



Date of disclosure:


21 NOVEMBER 2018




Contact name:


Craig Horsley




Telephone number:


+44(141) 245 7736



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
 
 
 
 
 
 
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
 
4.   KEY INFORMATION
 



Identity of person whose open positions are being disclosed:


Morgan Stanley MUFG Securities Co., Ltd.




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical Company Limited



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 
 



Class of relevant security


Product Description e.g call option


Written or Purchased


Number of Securities to which option or derivative relates


Exercise Price Per Unit (USD)


Type


Expiry Date




 Ordinary


 PUT


PURCHASED


 125,000


4507.0000 JPY


 European


13/12/2019




 Ordinary


 CALL


PURCHASED


 125,000


4507.0000 JPY


 European


13/12/2019




 Ordinary


 PUT


PURCHASED


 60,000


4596.0000 JPY


 European


14/06/2019




 Ordinary


 CALL


PURCHASED


 60,000


4596.0000 JPY


 European


14/06/2019




 Ordinary


 PUT


PURCHASED


 65,000


4414.0000 JPY


 European


14/06/2019




 Ordinary


 CALL


PURCHASED


 65,000


4414.0000 JPY


 European


14/06/2019




 Ordinary


 PUT


PURCHASED


 65,000


4414.0000 JPY


 European


13/12/2019




 Ordinary


 CALL


PURCHASED


 65,000


4414.0000 JPY


 European


13/12/2019



 
 
 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.
 
The currency of all prices and other monetary amounts should be stated.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEANFFASSPFEF